WestRock Company (WRK)

Prev Close 35.49
Day Low/High 0.00 / 0.00
52 Wk Low/High 35.20 / 67.01
Exchange NYSE
Shares Outstanding 255.37B
Market Cap 9.06B
Div & Yield N.A. (N.A)

Latest News

WestRock: An Undervalued High-Yield Dividend Stock on the Mend

The stock looks very attractive for value and income investors alike.

WestRock Could Be Starting a New Base Pattern, So Be Patient

WestRock Could Be Starting a New Base Pattern, So Be Patient

More sideways price action is needed before the long side becomes more attractive.

Last Week's Portfolio Changes

We exited one position and downgraded another last week.

Weekly Roundup

Markets remain treacherous as investors are becoming increasingly concerned about a number of factors.

Our Game Plan for Today's Fed Announcement

Some general ideas of what stocks we think can be bought in the event of a market-wide selloff.

Adding to UnitedHealth Before the Close

We are continuing our strategy of upgrading the portfolio by taking out the weak names and adding to one of our favorite names in healthcare.

Markets Mixed on Tuesday

All the market's attention is pointing to tomorrow's FOMC meeting announcement and Fed Chairman Powell's press conference.

Adding to Cisco Systems

We want to reallocate recent funds raised and buy high-quality stocks that have pulled back.

Adding to JP Morgan and Five Below

We are interested in doing a bit of buying this afternoon with the funds raised from our WestRock exit.

Exiting WestRock

Our patience has grown even thinner with this name, especially in this volatile market.

Weekly Roundup

It was another volatile week in the U.S. equity markets.

Trimming Abbott Labs and Textron

We need cash to give us optionality to buy a market pullback scenario, but we also need to let our winners run.

Video: Jim's Daily Rundown for Wednesday

Jim discusses our financials, our WestRock trim, and more!

Trimming WestRock Into a Strong Open

We'll take advantage of the market's early strength to sell shares of a weaker name and raise cash.

Palo Alto Networks' Shares Jump on Tuesday After Positive Note From Analysts

Deutsche Bank analysts walked away from their meeting with CEO Nikesh Arora bullish on the company's stock.

Video: Jim's Daily Rundown for Tuesday

Jim discusses Apple's move on Monday, CVS Health, our decision to trim WestRock into the market's open, and more!

Trimming WestRock

With the market showing strength this morning, we find it necessary to sell some of a losing position we are less confident about, so we can rebuild our cash position.

Monday's Portfolio News

We look at Apple, Facebook, Raytheon, BP and WestRock.

Jim's Daily Rundown

Jim discusses his approach to this market, CVS Health, Apple, WestRock, Johnson & Johnson, and much more!

Weekly Roundup

Once again, it was a volatile week for U.S. equities.

Recounting the Strategic Moves We Made in the Past Few Weeks

We leveraged a disciplined portfolio management strategy to help navigate the stormy waters.

Playing the Trade-War Truce: Cramer's 'Mad Money' Recap (Monday 12/3/18)

Playing the Trade-War Truce: Cramer's 'Mad Money' Recap (Monday 12/3/18)

Jim Cramer looks at what companies are likely to benefit in the wake of President Trump's decision to hold off raising tariffs on Chinese goods.

Video: Jim's Daily Rundown for Monday

Jim discusses our energy names, our FAANG stocks, Goldman Sachs, Textron, WestRock, Kohl's, Palo Alto Networks, and more!

PMI Advanced in November

The reading points to ongoing strength in the U.S. economy.

Selling Some Honeywell and WestRock

We are trimming a few more positions into Monday's market strength that is driven by the temporary truce in the U.S.-Chinese trade war.

Last Week's Portfolio Changes

We raised one price target and downgraded three positions last week.

Weekly Roundup

The market responded favorably after Fed Chair Jerome Powell portrayed a more dovish stance on interest rates.

Trimming WestRock and Danaher

Following these trades, we will have replenished our cash position by roughly $42,000 this week.

TheStreet Quant Rating: C+ (Hold)